Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Highly Predictive Genetic Markers Distinguish Drug-Type from Fiber-Type Cannabis sativa L.

Cascini F, Farcomeni A, Migliorini D, Baldassarri L, Boschi I, Martello S, Amaducci S, Lucini L, Bernardi J.

Plants (Basel). 2019 Nov 12;8(11). pii: E496. doi: 10.3390/plants8110496.

PMID:
31718081
2.

Current strategies for vaccination in glioblastoma.

Dutoit V, Migliorini D, Dietrich PY.

Curr Opin Oncol. 2019 Nov;31(6):514-521. doi: 10.1097/CCO.0000000000000575.

PMID:
31403483
3.

Correction for Danovi et al., "Amplification of Mdmx (or Mdm4) Directly Contributes to Tumor Formation by Inhibiting p53 Tumor Suppressor Activity".

Danovi D, Meulmeester E, Pasini D, Migliorini D, Capra M, Frenk R, de Graaf P, Francoz S, Gasparini P, Gobbi A, Helin K, Pelicci PG, Jochemsen AG, Marine JC.

Mol Cell Biol. 2019 Jul 16;39(15). pii: e00150-19. doi: 10.1128/MCB.00150-19. Print 2019 Aug 1. No abstract available.

4.

Keeping the Engine Running: The Relevance and Predictive Value of Preclinical Models for CAR-T Cell Development.

Migliorini D, Mason NJ, Posey AD.

ILAR J. 2018 Dec 31;59(3):276-285. doi: 10.1093/ilar/ilz009.

PMID:
31095687
5.

Exploratory Study of the Effect of IMA950/Poly-ICLC Vaccination on Response to Bevacizumab in Relapsing High-Grade Glioma Patients.

Boydell E, Marinari E, Migliorini D, Dietrich PY, Patrikidou A, Dutoit V.

Cancers (Basel). 2019 Apr 2;11(4). pii: E464. doi: 10.3390/cancers11040464.

6.

Phase I/II trial testing safety and immunogenicity of the multipeptide IMA950/poly-ICLC vaccine in newly diagnosed adult malignant astrocytoma patients.

Migliorini D, Dutoit V, Allard M, Hallez NG, Marinari E, Widmer V, Philippin G, Corlazzoli F, Gustave R, Kreutzfeldt M, Blazek N, Wasem J, Hottinger A, Koka A, Momjian S, Lobrinus A, Merkler D, Vargas MI, Walker PR, Patrikidou A, Dietrich PY.

Neuro Oncol. 2019 Feb 12. doi: 10.1093/neuonc/noz040. [Epub ahead of print]

PMID:
30753611
7.

Publisher Correction: Actively personalized vaccination trial for newly diagnosed glioblastoma.

Hilf N, Kuttruff-Coqui S, Frenzel K, Bukur V, Stevanović S, Gouttefangeas C, Platten M, Tabatabai G, Dutoit V, van der Burg SH, Straten PT, Martinez-Ricarte F, Ponsati B, Okada H, Lassen U, Admon A, Ottensmeier CH, Ulges A, Kreiter S, von Deimling A, Skardelly M, Migliorini D, Kroep JR, Idorn M, Rodon J, Piro J, Poulsen HS, Shraibman B, McCann K, Mendrzyk R, Lower M, Stieglbauer M, Britten CM, Capper D, Welters MJP, Sahuquillo J, Kiesel K, Derhovanessian E, Rusch E, Bunse L, Song C, Heesch S, Wagner C, Kemmer-Bruck A, Ludwig J, Castle JC, Schoor O, Tadmor AD, Green E, Fritsche J, Meyer M, Pawlowski N, Dorner S, Hoffgaard F, Rossler B, Maurer D, Weinschenk T, Reinhardt C, Huber C, Rammensee HG, Singh-Jasuja H, Sahin U, Dietrich PY, Wick W.

Nature. 2019 Feb;566(7745):E13. doi: 10.1038/s41586-019-0959-z.

PMID:
30733620
8.

Correction to "Surface Reaction Barriometry: Methane Dissociation on Flat and Stepped Transition-Metal Surfaces".

Migliorini D, Chadwick H, Nattino F, Gutiérrez-González A, Dombrowski E, High EA, Guo H, Utz AL, Jackson B, Beck RD, Kroes GJ.

J Phys Chem Lett. 2019 Feb 7;10(3):661-662. doi: 10.1021/acs.jpclett.9b00186. Epub 2019 Jan 30. No abstract available.

9.

Diplodia Tip Blight on Its Way to the North: Drivers of Disease Emergence in Northern Europe.

Brodde L, Adamson K, Julio Camarero J, Castaño C, Drenkhan R, Lehtijärvi A, Luchi N, Migliorini D, Sánchez-Miranda Á, Stenlid J, Özdağ Ş, Oliva J.

Front Plant Sci. 2019 Jan 9;9:1818. doi: 10.3389/fpls.2018.01818. eCollection 2018.

10.

HOD on Ni(111): Ab Initio molecular dynamics prediction of molecular beam experiments.

Migliorini D, Nattino F, Tiwari AK, Kroes GJ.

J Chem Phys. 2018 Dec 28;149(24):244706. doi: 10.1063/1.5059357.

PMID:
30599742
11.

Actively personalized vaccination trial for newly diagnosed glioblastoma.

Hilf N, Kuttruff-Coqui S, Frenzel K, Bukur V, Stevanović S, Gouttefangeas C, Platten M, Tabatabai G, Dutoit V, van der Burg SH, Thor Straten P, Martínez-Ricarte F, Ponsati B, Okada H, Lassen U, Admon A, Ottensmeier CH, Ulges A, Kreiter S, von Deimling A, Skardelly M, Migliorini D, Kroep JR, Idorn M, Rodon J, Piró J, Poulsen HS, Shraibman B, McCann K, Mendrzyk R, Löwer M, Stieglbauer M, Britten CM, Capper D, Welters MJP, Sahuquillo J, Kiesel K, Derhovanessian E, Rusch E, Bunse L, Song C, Heesch S, Wagner C, Kemmer-Brück A, Ludwig J, Castle JC, Schoor O, Tadmor AD, Green E, Fritsche J, Meyer M, Pawlowski N, Dorner S, Hoffgaard F, Rössler B, Maurer D, Weinschenk T, Reinhardt C, Huber C, Rammensee HG, Singh-Jasuja H, Sahin U, Dietrich PY, Wick W.

Nature. 2019 Jan;565(7738):240-245. doi: 10.1038/s41586-018-0810-y. Epub 2018 Dec 19. Erratum in: Nature. 2019 Feb;566(7745):E13.

PMID:
30568303
12.

Dissociation of CHD3 on Cu(111), Cu(211), and single atom alloys of Cu(111).

Gerrits N, Migliorini D, Kroes GJ.

J Chem Phys. 2018 Dec 14;149(22):224701. doi: 10.1063/1.5053990.

PMID:
30553257
13.

Checkpoint Blockade Reverses Anergy in IL-13Rα2 Humanized scFv-Based CAR T Cells to Treat Murine and Canine Gliomas.

Yin Y, Boesteanu AC, Binder ZA, Xu C, Reid RA, Rodriguez JL, Cook DR, Thokala R, Blouch K, McGettigan-Croce B, Zhang L, Konradt C, Cogdill AP, Panjwani MK, Jiang S, Migliorini D, Dahmane N, Posey AD Jr, June CH, Mason NJ, Lin Z, O'Rourke DM, Johnson LA.

Mol Ther Oncolytics. 2018 Aug 28;11:20-38. doi: 10.1016/j.omto.2018.08.002. eCollection 2018 Dec 21.

14.

Incident Angle Dependence of CHD3 Dissociation on the Stepped Pt(211) Surface.

Chadwick H, Gutiérrez-González A, Migliorini D, Beck RD, Kroes GJ.

J Phys Chem C Nanomater Interfaces. 2018 Aug 30;122(34):19652-19660. doi: 10.1021/acs.jpcc.8b05887. Epub 2018 Jul 31.

15.

Methane on a stepped surface: Dynamical insights on the dissociation of CHD3 on Pt(111) and Pt(211).

Migliorini D, Chadwick H, Kroes GJ.

J Chem Phys. 2018 Sep 7;149(9):094701. doi: 10.1063/1.5046065.

PMID:
30195319
16.

CHD3 dissociation on Pt(111): A comparison of the reaction dynamics based on the PBE functional and on a specific reaction parameter functional.

Chadwick H, Migliorini D, Kroes GJ.

J Chem Phys. 2018 Jul 28;149(4):044701. doi: 10.1063/1.5039458.

PMID:
30068208
17.

Glycan-directed CAR-T cells.

Steentoft C, Migliorini D, King TR, Mandel U, June CH, Posey AD Jr.

Glycobiology. 2018 Sep 1;28(9):656-669. doi: 10.1093/glycob/cwy008. Review.

PMID:
29370379
18.

Tracing the role of human civilization in the globalization of plant pathogens.

Santini A, Liebhold A, Migliorini D, Woodward S.

ISME J. 2018 Mar;12(3):647-652. doi: 10.1038/s41396-017-0013-9. Epub 2018 Jan 12. No abstract available.

19.

Antigenic expression and spontaneous immune responses support the use of a selected peptide set from the IMA950 glioblastoma vaccine for immunotherapy of grade II and III glioma.

Dutoit V, Migliorini D, Ranzanici G, Marinari E, Widmer V, Lobrinus JA, Momjian S, Costello J, Walker PR, Okada H, Weinschenk T, Herold-Mende C, Dietrich PY.

Oncoimmunology. 2017 Nov 7;7(2):e1391972. doi: 10.1080/2162402X.2017.1391972. eCollection 2018.

20.

Rapidly Growing Pulmonary Metastasis from Anaplastic Meningioma with Lethal Outcome: A Case Report.

Corniola MV, Landis BN, Migliorini D, Lobrinus JA, Ares C, Schaller K, Jägersberg M.

J Neurol Surg Rep. 2017 Oct;78(4):e129-e134. doi: 10.1055/s-0037-1615808. Epub 2017 Dec 28.

21.

CAR T-Cell Therapies in Glioblastoma: A First Look.

Migliorini D, Dietrich PY, Stupp R, Linette GP, Posey AD Jr, June CH.

Clin Cancer Res. 2018 Feb 1;24(3):535-540. doi: 10.1158/1078-0432.CCR-17-2871. Epub 2017 Nov 20.

22.

First report of clinical responses to immunotherapy in 3 relapsing cases of chordoma after failure of standard therapies.

Migliorini D, Mach N, Aguiar D, Vernet R, Landis BN, Becker M, McKee T, Dutoit V, Dietrich PY.

Oncoimmunology. 2017 Jun 21;6(8):e1338235. doi: 10.1080/2162402X.2017.1338235. eCollection 2017.

23.

Surface Reaction Barriometry: Methane Dissociation on Flat and Stepped Transition-Metal Surfaces.

Migliorini D, Chadwick H, Nattino F, Gutiérrez-González A, Dombrowski E, High EA, Guo H, Utz AL, Jackson B, Beck RD, Kroes GJ.

J Phys Chem Lett. 2017 Sep 7;8(17):4177-4182. doi: 10.1021/acs.jpclett.7b01905. Epub 2017 Aug 22. Erratum in: J Phys Chem Lett. 2019 Feb 7;10(3):661-662.

24.

[Brain tumor immunotherapy: Illusion or hope?]

Migliorini D, Dutoit V, Walker PR, Dietrich PY.

Bull Cancer. 2017 May;104(5):476-484. doi: 10.1016/j.bulcan.2017.01.014. Epub 2017 Mar 17. Review. French.

PMID:
28318492
25.

BRAF/MEK double blockade in refractory anaplastic pleomorphic xanthoastrocytoma.

Migliorini D, Aguiar D, Vargas MI, Lobrinus A, Dietrich PY.

Neurology. 2017 Mar 28;88(13):1291-1293. doi: 10.1212/WNL.0000000000003767. Epub 2017 Feb 24. No abstract available.

26.

Immunotherapy of Malignant Tumors in the Brain: How Different from Other Sites?

Dutoit V, Migliorini D, Dietrich PY, Walker PR.

Front Oncol. 2016 Dec 7;6:256. doi: 10.3389/fonc.2016.00256. eCollection 2016. Review.

27.

Upfront targeted therapy for symptomatic melanoma brain metastases: paradigm changing?

Migliorini D, Fertani S, Dietrich PY.

CNS Oncol. 2016 Oct;5(4):199-201. doi: 10.2217/cns-2016-0019. Epub 2016 Sep 12.

28.

Behavioral management of headache in children and adolescents.

Faedda N, Cerutti R, Verdecchia P, Migliorini D, Arruda M, Guidetti V.

J Headache Pain. 2016 Dec;17(1):80. doi: 10.1186/s10194-016-0671-4. Epub 2016 Sep 5. Review.

29.

Chemically Accurate Simulation of a Polyatomic Molecule-Metal Surface Reaction.

Nattino F, Migliorini D, Kroes GJ, Dombrowski E, High EA, Killelea DR, Utz AL.

J Phys Chem Lett. 2016 Jul 7;7(13):2402-6. doi: 10.1021/acs.jpclett.6b01022. Epub 2016 Jun 15.

30.

[Immunotherapy for brain tumors: obstacles and perspectives].

Migliorini D, Dietrich PY.

Rev Med Suisse. 2016 Apr 27;12(516):828-31. French.

PMID:
27281940
31.

[Multidisciplinar approach to the management of gliomas].

Moura B, Migliorini D, Bourhis J, Daniel R, Levivier M, Hottinger AF.

Rev Med Suisse. 2016 Apr 27;12(516):821-5. French.

PMID:
27281939
32.

Application of van der Waals functionals to the calculation of dissociative adsorption of N2 on W(110) for static and dynamic systems.

Migliorini D, Nattino F, Kroes GJ.

J Chem Phys. 2016 Feb 28;144(8):084702. doi: 10.1063/1.4942198.

PMID:
26931713
33.

Methane dissociation on Pt(111): Searching for a specific reaction parameter density functional.

Nattino F, Migliorini D, Bonfanti M, Kroes GJ.

J Chem Phys. 2016 Jan 28;144(4):044702. doi: 10.1063/1.4939520.

PMID:
26827223
34.

Recurrent multiple CNS hemangioblastomas with VHL disease treated with pazopanib: a case report and literature review.

Migliorini D, Haller S, Merkler D, Pugliesi-Rinaldi A, Koka A, Schaller K, Leemann B, Dietrich PY.

CNS Oncol. 2015;4(6):387-92. doi: 10.2217/cns.15.22. Epub 2015 Oct 26. Review.

35.

Patterns of care in recurrent glioblastoma in Switzerland: a multicentre national approach based on diagnostic nodes.

Hundsberger T, Hottinger AF, Roelcke U, Roth P, Migliorini D, Dietrich PY, Conen K, Pesce G, Hermann E, Pica A, Gross MW, Brügge D, Plasswilm L, Weller M, Putora PM.

J Neurooncol. 2016 Jan;126(1):175-183. doi: 10.1007/s11060-015-1957-0. Epub 2015 Oct 12.

36.

Immunotherapy of Brain Tumors.

Dutoit V, Migliorini D, Walker PR, Dietrich PY.

Prog Tumor Res. 2015;42:11-21. doi: 10.1159/000436986. Epub 2015 Sep 4. Review.

PMID:
26376741
37.

The CD40/CD40L axis in glioma progression and therapy.

Walker PR, Migliorini D.

Neuro Oncol. 2015 Nov;17(11):1428-30. doi: 10.1093/neuonc/nov138. Epub 2015 Jul 22. No abstract available.

38.

[Cerebral lymphoma: a classic presentation?].

Nemitz I, Migliorini D, Dietrich PY.

Rev Med Suisse. 2015 Feb 4;11(460):371-3. French. No abstract available.

PMID:
25854049
39.

Maximizing output from current glioma vaccine trials to construct robust next-generation immunotherapies.

Migliorini D, Dietrich PY, Walker PR.

Immunotherapy. 2013 Nov;5(11):1147-50. doi: 10.2217/imt.13.115. Review. No abstract available.

40.

Differential requirement for the dual functions of β-catenin in embryonic stem cell self-renewal and germ layer formation.

Lyashenko N, Winter M, Migliorini D, Biechele T, Moon RT, Hartmann C.

Nat Cell Biol. 2011 Jun 19;13(7):753-61. doi: 10.1038/ncb2260.

41.

Cop1 constitutively regulates c-Jun protein stability and functions as a tumor suppressor in mice.

Migliorini D, Bogaerts S, Defever D, Vyas R, Denecker G, Radaelli E, Zwolinska A, Depaepe V, Hochepied T, Skarnes WC, Marine JC.

J Clin Invest. 2011 Apr;121(4):1329-43. doi: 10.1172/JCI45784. Epub 2011 Mar 14.

42.

DNA damage-induced phosphorylation of MdmX at serine 367 activates p53 by targeting MdmX for Mdm2-dependent degradation.

Okamoto K, Kashima K, Pereg Y, Ishida M, Yamazaki S, Nota A, Teunisse A, Migliorini D, Kitabayashi I, Marine JC, Prives C, Shiloh Y, Jochemsen AG, Taya Y.

Mol Cell Biol. 2005 Nov;25(21):9608-20.

43.

Amplification of Mdmx (or Mdm4) directly contributes to tumor formation by inhibiting p53 tumor suppressor activity.

Danovi D, Meulmeester E, Pasini D, Migliorini D, Capra M, Frenk R, de Graaf P, Francoz S, Gasparini P, Gobbi A, Helin K, Pelicci PG, Jochemsen AG, Marine JC.

Mol Cell Biol. 2004 Jul;24(13):5835-43. Erratum in: Mol Cell Biol. 2019 Jul 16;39(15):.

44.

Mdm4 (Mdmx) regulates p53-induced growth arrest and neuronal cell death during early embryonic mouse development.

Migliorini D, Lazzerini Denchi E, Danovi D, Jochemsen A, Capillo M, Gobbi A, Helin K, Pelicci PG, Marine JC.

Mol Cell Biol. 2002 Aug;22(15):5527-38.

45.

RNase E and polyadenyl polymerase I are involved in maturation of CI RNA, the P4 phage immunity factor.

Briani F, Del Vecchio E, Migliorini D, Hajnsdorf E, Régnier P, Ghisotti D, Dehò G.

J Mol Biol. 2002 Apr 26;318(2):321-31.

PMID:
12051840
46.

Hdmx recruitment into the nucleus by Hdm2 is essential for its ability to regulate p53 stability and transactivation.

Migliorini D, Danovi D, Colombo E, Carbone R, Pelicci PG, Marine JC.

J Biol Chem. 2002 Mar 1;277(9):7318-23. Epub 2001 Dec 13.

47.

Genital ulcer in an AIDS patient with disseminated leishmaniasis.

Agostoni C, Migliorini D, Dorigoni N, Malfitano A, Scaglia M.

Eur J Clin Microbiol Infect Dis. 1998 Nov;17(11):813-4. No abstract available.

PMID:
9923531
48.

[Doppler echography and color Doppler echography in the assessment of the vascular functional aspects of medical nephropathies].

Argalia G, D'ambrosio F, Mignosi U, Migliorini D, Lucarelli F, Giuseppetti GM, Fanciulli E, Mioli V.

Radiol Med. 1995 Apr;89(4):464-9. Italian.

PMID:
7597228
49.

[Treatment of Plummer's adenoma: correlation between ultrasonography-guided percutaneous injection of ethanol and autoimmunity].

Argalia G, Migliorini D, Salvolini L, Macellari L, Giuseppetti GM, Morosini PP, Arnaldi G, Vecchi A, Gusella P.

Radiol Med. 1993 Apr;85(4):462-6. Italian.

PMID:
8516475
50.

[Relationship between clinical diagnosis and microbiological diagnosis of symptomatic vaginitis].

Sagone I, Zacharias G, Angeli M, Migliorini D, Saudelli M.

Clin Ter. 1989 Jan 15;128(1):21-5. Italian.

PMID:
2525988

Supplemental Content

Loading ...
Support Center